

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.52168990 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.22084284 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.83418995 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.83418995 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.74772541 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.74772541 |
| 7 | B cell receptor signaling pathway (GO:0050853) | 5.69191195 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.62632166 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.44806486 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.37506816 |
| 11 | negative T cell selection (GO:0043383) | 5.03177636 |
| 12 | negative thymic T cell selection (GO:0045060) | 4.97785269 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 4.89109455 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.88767388 |
| 15 | negative regulation of phagocytosis (GO:0050765) | 4.74130446 |
| 16 | positive thymic T cell selection (GO:0045059) | 4.72897866 |
| 17 | T cell migration (GO:0072678) | 4.67409840 |
| 18 | positive regulation of B cell differentiation (GO:0045579) | 4.58320475 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 4.57254327 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 4.57254327 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.57254327 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.57254327 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.57254327 |
| 24 | modulation by symbiont of host immune response (GO:0052553) | 4.57254327 |
| 25 | detection of bacterium (GO:0016045) | 4.53192945 |
| 26 | positive T cell selection (GO:0043368) | 4.51423149 |
| 27 | detection of other organism (GO:0098543) | 4.50006478 |
| 28 | T cell selection (GO:0045058) | 4.48545870 |
| 29 | neutrophil activation involved in immune response (GO:0002283) | 4.47502074 |
| 30 | response to interleukin-15 (GO:0070672) | 4.47017306 |
| 31 | regulation of B cell differentiation (GO:0045577) | 4.44106485 |
| 32 | thymic T cell selection (GO:0045061) | 4.41830166 |
| 33 | mast cell activation involved in immune response (GO:0002279) | 4.26181914 |
| 34 | mast cell degranulation (GO:0043303) | 4.26181914 |
| 35 | cellular response to interleukin-15 (GO:0071350) | 4.10220619 |
| 36 | mast cell activation (GO:0045576) | 4.08042972 |
| 37 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.02545524 |
| 38 | leukocyte aggregation (GO:0070486) | 4.00390111 |
| 39 | interferon-gamma production (GO:0032609) | 3.98740535 |
| 40 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.80687280 |
| 41 | V(D)J recombination (GO:0033151) | 3.76043969 |
| 42 | response to muramyl dipeptide (GO:0032495) | 3.74748807 |
| 43 | macrophage activation involved in immune response (GO:0002281) | 3.74545723 |
| 44 | T cell homeostasis (GO:0043029) | 3.70618872 |
| 45 | response to peptidoglycan (GO:0032494) | 3.67088073 |
| 46 | regulation of T cell tolerance induction (GO:0002664) | 3.65660943 |
| 47 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.65469609 |
| 48 | immunoglobulin mediated immune response (GO:0016064) | 3.64934864 |
| 49 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.63844689 |
| 50 | T cell receptor signaling pathway (GO:0050852) | 3.63128261 |
| 51 | positive regulation of granulocyte differentiation (GO:0030854) | 3.54227541 |
| 52 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.50466021 |
| 53 | negative regulation of interleukin-12 production (GO:0032695) | 3.49165353 |
| 54 | regulation of tolerance induction (GO:0002643) | 3.45916165 |
| 55 | detection of external biotic stimulus (GO:0098581) | 3.41732921 |
| 56 | ribosomal small subunit assembly (GO:0000028) | 3.39421367 |
| 57 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.35157826 |
| 58 | cellular extravasation (GO:0045123) | 3.31317433 |
| 59 | regulation of mast cell degranulation (GO:0043304) | 3.30907227 |
| 60 | myeloid cell activation involved in immune response (GO:0002275) | 3.29949238 |
| 61 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.26899630 |
| 62 | lymphocyte homeostasis (GO:0002260) | 3.25592481 |
| 63 | cAMP catabolic process (GO:0006198) | 3.25280531 |
| 64 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.23914233 |
| 65 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.23914233 |
| 66 | cellular response to zinc ion (GO:0071294) | 3.22228360 |
| 67 | mature B cell differentiation (GO:0002335) | 3.21671603 |
| 68 | angiogenesis involved in wound healing (GO:0060055) | 3.18578078 |
| 69 | type I interferon signaling pathway (GO:0060337) | 3.17267928 |
| 70 | cellular response to type I interferon (GO:0071357) | 3.17267928 |
| 71 | response to type I interferon (GO:0034340) | 3.16358365 |
| 72 | granulocyte activation (GO:0036230) | 3.14755263 |
| 73 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.14208310 |
| 74 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.14208310 |
| 75 | regulation of regulatory T cell differentiation (GO:0045589) | 3.13909969 |
| 76 | negative regulation of innate immune response (GO:0045824) | 3.13803400 |
| 77 | leukocyte degranulation (GO:0043299) | 3.13749237 |
| 78 | natural killer cell differentiation (GO:0001779) | 3.12351855 |
| 79 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.10989252 |
| 80 | response to host immune response (GO:0052572) | 3.10989252 |
| 81 | megakaryocyte development (GO:0035855) | 3.10858863 |
| 82 | positive regulation of tolerance induction (GO:0002645) | 3.09906992 |
| 83 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.07916507 |
| 84 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.07458636 |
| 85 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.06644743 |
| 86 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.05965260 |
| 87 | germinal center formation (GO:0002467) | 3.05290876 |
| 88 | regulation of granulocyte differentiation (GO:0030852) | 3.04950394 |
| 89 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.03840564 |
| 90 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.03830807 |
| 91 | adenosine receptor signaling pathway (GO:0001973) | 3.03610762 |
| 92 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.01424707 |
| 93 | microglial cell activation (GO:0001774) | 3.00666023 |
| 94 | regulation of leukocyte degranulation (GO:0043300) | 3.00074367 |
| 95 | B cell proliferation (GO:0042100) | 2.99194296 |
| 96 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.98006364 |
| 97 | detection of biotic stimulus (GO:0009595) | 2.97387987 |
| 98 | T cell costimulation (GO:0031295) | 2.96941855 |
| 99 | adaptation of signaling pathway (GO:0023058) | 2.93548599 |
| 100 | response to host defenses (GO:0052200) | 2.92140496 |
| 101 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.92140496 |
| 102 | response to host (GO:0075136) | 2.92140496 |
| 103 | histone H3-K4 trimethylation (GO:0080182) | 2.90304900 |
| 104 | negative regulation of interleukin-6 production (GO:0032715) | 2.89873274 |
| 105 | lymphocyte costimulation (GO:0031294) | 2.89551556 |
| 106 | B cell mediated immunity (GO:0019724) | 2.89467696 |
| 107 | leukocyte homeostasis (GO:0001776) | 2.88695439 |
| 108 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.88529617 |
| 109 | positive regulation of histone deacetylation (GO:0031065) | 2.86975625 |
| 110 | negative regulation of T cell mediated immunity (GO:0002710) | 2.85603369 |
| 111 | positive regulation of interleukin-2 production (GO:0032743) | 2.84190669 |
| 112 | * positive regulation of Rap GTPase activity (GO:0032854) | 2.83419953 |
| 113 | negative regulation of histone methylation (GO:0031061) | 2.82908948 |
| 114 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.81241682 |
| 115 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.79236678 |
| 116 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.77845589 |
| 117 | positive regulation of isotype switching (GO:0045830) | 2.75885930 |
| 118 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.74175474 |
| 119 | cyclic nucleotide catabolic process (GO:0009214) | 2.74032950 |
| 120 | respiratory burst (GO:0045730) | 2.71441040 |
| 121 | response to protozoan (GO:0001562) | 2.69750927 |
| 122 | leukocyte cell-cell adhesion (GO:0007159) | 2.69514632 |
| 123 | mature B cell differentiation involved in immune response (GO:0002313) | 2.69316995 |
| 124 | viral transcription (GO:0019083) | 2.67882462 |
| 125 | Peyers patch development (GO:0048541) | 2.67279409 |
| 126 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.67279409 |
| 127 | natural killer cell activation (GO:0030101) | 2.66102377 |
| 128 | lymph node development (GO:0048535) | 2.65394209 |
| 129 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.64630247 |
| 130 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.64478261 |
| 131 | tachykinin receptor signaling pathway (GO:0007217) | 2.64344558 |
| 132 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.64030962 |
| 133 | B cell activation (GO:0042113) | 2.63790330 |
| 134 | synaptic transmission, dopaminergic (GO:0001963) | 2.61720321 |
| 135 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.61346684 |
| 136 | positive regulation of immunoglobulin production (GO:0002639) | 2.59456640 |
| 137 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.58561652 |
| 138 | defense response to protozoan (GO:0042832) | 2.57485380 |
| 139 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.57272537 |
| 140 | positive regulation of lamellipodium assembly (GO:0010592) | 2.56635190 |
| 141 | B cell differentiation (GO:0030183) | 2.55478584 |
| 142 | defense response to fungus (GO:0050832) | 2.55048686 |
| 143 | B cell homeostasis (GO:0001782) | 2.54998521 |
| 144 | activated T cell proliferation (GO:0050798) | 2.54406624 |
| 145 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.53466718 |
| 146 | prepulse inhibition (GO:0060134) | 2.53180414 |
| 147 | tolerance induction (GO:0002507) | 2.52951243 |
| 148 | DNA unwinding involved in DNA replication (GO:0006268) | 2.52158403 |
| 149 | neutrophil activation (GO:0042119) | 2.52097786 |
| 150 | mononuclear cell proliferation (GO:0032943) | 2.51611415 |
| 151 | T cell differentiation (GO:0030217) | 2.51507640 |
| 152 | myeloid dendritic cell activation (GO:0001773) | 2.51342149 |
| 153 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.50801307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.30307466 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.73734535 |
| 3 | * MYC_22102868_ChIP-Seq_BL_Human | 4.57108674 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.64847518 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.56551300 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.49567588 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.45590653 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.11204437 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.03805625 |
| 10 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.98386164 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.83870916 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.79414425 |
| 13 | UTX_26944678_Chip-Seq_JUKART_Human | 2.70629378 |
| 14 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.69225411 |
| 15 | * MYB_26560356_Chip-Seq_TH2_Human | 2.66263571 |
| 16 | * MAF_26560356_Chip-Seq_TH1_Human | 2.63171584 |
| 17 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.51788189 |
| 18 | * MYB_26560356_Chip-Seq_TH1_Human | 2.47009124 |
| 19 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.42768526 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.42028204 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.37801292 |
| 22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.37256455 |
| 23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.31346067 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.30818720 |
| 25 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.27011083 |
| 26 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.25411688 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.15521021 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13019891 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.06874510 |
| 30 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.06143209 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.03344630 |
| 32 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.01295844 |
| 33 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.99186083 |
| 34 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.97038402 |
| 35 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92363902 |
| 36 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.92238047 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.91284941 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.88551533 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87467631 |
| 40 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.86807237 |
| 41 | * MAF_26560356_Chip-Seq_TH2_Human | 1.84812883 |
| 42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.83334401 |
| 43 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.82889671 |
| 44 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.81497283 |
| 45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79152180 |
| 46 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.72839082 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69261448 |
| 48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68265666 |
| 49 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.67280288 |
| 50 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62546107 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.61772225 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60666120 |
| 53 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58018308 |
| 54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55395527 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47745635 |
| 56 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.46272813 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46016000 |
| 58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39304258 |
| 59 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.36645192 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35789586 |
| 61 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.33310908 |
| 62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.33025984 |
| 63 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32726642 |
| 64 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.32553280 |
| 65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.30767077 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.30552931 |
| 67 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30306215 |
| 68 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29044206 |
| 69 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27182113 |
| 70 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.25345517 |
| 71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24533001 |
| 72 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.22969930 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20140766 |
| 74 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20043522 |
| 75 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.18278201 |
| 76 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15522002 |
| 77 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.14647901 |
| 78 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12699840 |
| 79 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12530976 |
| 80 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11247231 |
| 81 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10273506 |
| 82 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.09014639 |
| 83 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08342332 |
| 84 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07478276 |
| 85 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06383173 |
| 86 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06243107 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06228080 |
| 88 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06165328 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05979075 |
| 90 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05869870 |
| 91 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03185237 |
| 92 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.02717800 |
| 93 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02494603 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01683763 |
| 95 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.98856926 |
| 96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98568192 |
| 97 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97801810 |
| 98 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97551119 |
| 99 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97381806 |
| 100 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.96970787 |
| 101 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96892027 |
| 102 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.96557485 |
| 103 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96444910 |
| 104 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96350945 |
| 105 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95526840 |
| 106 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.92740783 |
| 107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90246939 |
| 108 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.90069388 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87652201 |
| 110 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.86899662 |
| 111 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85301726 |
| 112 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.85180928 |
| 113 | P68_20966046_ChIP-Seq_HELA_Human | 0.85108801 |
| 114 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84601177 |
| 115 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.83317229 |
| 116 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.82847996 |
| 117 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82648877 |
| 118 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.82119218 |
| 119 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.79629116 |
| 120 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.79365601 |
| 121 | P300_27268052_Chip-Seq_Bcells_Human | 0.77115917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 4.38991925 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.76987597 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.63235522 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.41213663 |
| 5 | MP0001800_abnormal_humoral_immune | 3.37587947 |
| 6 | MP0001790_abnormal_immune_system | 3.05756037 |
| 7 | MP0005387_immune_system_phenotype | 3.05756037 |
| 8 | MP0000685_abnormal_immune_system | 3.04572944 |
| 9 | MP0003303_peritoneal_inflammation | 2.93883517 |
| 10 | MP0002398_abnormal_bone_marrow | 2.87871496 |
| 11 | MP0005671_abnormal_response_to | 2.84852103 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.74546141 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.70260814 |
| 14 | MP0001819_abnormal_immune_cell | 2.68552278 |
| 15 | MP0002723_abnormal_immune_serum | 2.60570015 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.49889320 |
| 17 | MP0000716_abnormal_immune_system | 2.49314643 |
| 18 | MP0004808_abnormal_hematopoietic_stem | 2.45737739 |
| 19 | MP0000689_abnormal_spleen_morphology | 2.40191942 |
| 20 | MP0002722_abnormal_immune_system | 2.31376813 |
| 21 | MP0000703_abnormal_thymus_morphology | 2.23976684 |
| 22 | MP0005025_abnormal_response_to | 2.18970090 |
| 23 | MP0009785_altered_susceptibility_to | 2.16485667 |
| 24 | MP0002429_abnormal_blood_cell | 2.06965435 |
| 25 | MP0001873_stomach_inflammation | 2.05989715 |
| 26 | * MP0005464_abnormal_platelet_physiology | 2.05263416 |
| 27 | MP0002166_altered_tumor_susceptibility | 2.03153229 |
| 28 | MP0002419_abnormal_innate_immunity | 2.02175254 |
| 29 | MP0003436_decreased_susceptibility_to | 1.99041156 |
| 30 | MP0002405_respiratory_system_inflammati | 1.85624344 |
| 31 | MP0005174_abnormal_tail_pigmentation | 1.82899566 |
| 32 | MP0009278_abnormal_bone_marrow | 1.79755624 |
| 33 | MP0008260_abnormal_autophagy | 1.77036408 |
| 34 | MP0005409_darkened_coat_color | 1.73321487 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.72781063 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.72690193 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.72690193 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.72089427 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.70647739 |
| 40 | MP0003866_abnormal_defecation | 1.70350753 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.70055548 |
| 42 | MP0002006_tumorigenesis | 1.62507590 |
| 43 | MP0002148_abnormal_hypersensitivity_rea | 1.57598527 |
| 44 | MP0004381_abnormal_hair_follicle | 1.53961140 |
| 45 | MP0010094_abnormal_chromosome_stability | 1.46521316 |
| 46 | MP0003828_pulmonary_edema | 1.45465818 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.44640306 |
| 48 | MP0002009_preneoplasia | 1.37988363 |
| 49 | MP0001853_heart_inflammation | 1.37106208 |
| 50 | MP0003111_abnormal_nucleus_morphology | 1.29068064 |
| 51 | MP0008874_decreased_physiological_sensi | 1.28650824 |
| 52 | MP0008961_abnormal_basal_metabolism | 1.27748209 |
| 53 | MP0004859_abnormal_synaptic_plasticity | 1.26521093 |
| 54 | MP0008057_abnormal_DNA_replication | 1.20686654 |
| 55 | MP0005451_abnormal_body_composition | 1.19085864 |
| 56 | MP0000490_abnormal_crypts_of | 1.18527836 |
| 57 | MP0002019_abnormal_tumor_incidence | 1.18416632 |
| 58 | MP0005075_abnormal_melanosome_morpholog | 1.17502743 |
| 59 | MP0003787_abnormal_imprinting | 1.14988002 |
| 60 | MP0003077_abnormal_cell_cycle | 1.13518484 |
| 61 | MP0003724_increased_susceptibility_to | 1.12485444 |
| 62 | MP0004947_skin_inflammation | 1.10035209 |
| 63 | MP0000015_abnormal_ear_pigmentation | 1.09561510 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.08261035 |
| 65 | MP0001986_abnormal_taste_sensitivity | 1.07636721 |
| 66 | MP0008058_abnormal_DNA_repair | 1.07310385 |
| 67 | MP0004883_abnormal_blood_vessel | 1.07214370 |
| 68 | MP0002095_abnormal_skin_pigmentation | 1.00814615 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 0.99951996 |
| 70 | MP0005058_abnormal_lysosome_morphology | 0.96550522 |
| 71 | MP0001529_abnormal_vocalization | 0.95033815 |
| 72 | MP0003693_abnormal_embryo_hatching | 0.92402101 |
| 73 | MP0002132_abnormal_respiratory_system | 0.90525675 |
| 74 | MP0002933_joint_inflammation | 0.89086413 |
| 75 | MP0004510_myositis | 0.87782663 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 0.87736443 |
| 77 | MP0004130_abnormal_muscle_cell | 0.87601396 |
| 78 | MP0008569_lethality_at_weaning | 0.85492405 |
| 79 | MP0008469_abnormal_protein_level | 0.84737037 |
| 80 | MP0009745_abnormal_behavioral_response | 0.84095735 |
| 81 | MP0000858_altered_metastatic_potential | 0.83974908 |
| 82 | MP0003172_abnormal_lysosome_physiology | 0.79326311 |
| 83 | MP0005310_abnormal_salivary_gland | 0.79322416 |
| 84 | MP0002909_abnormal_adrenal_gland | 0.78799078 |
| 85 | MP0008004_abnormal_stomach_pH | 0.76078869 |
| 86 | MP0003635_abnormal_synaptic_transmissio | 0.75309682 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.75179756 |
| 88 | MP0003690_abnormal_glial_cell | 0.74735801 |
| 89 | MP0005423_abnormal_somatic_nervous | 0.74291329 |
| 90 | MP0005390_skeleton_phenotype | 0.73029615 |
| 91 | MP0003075_altered_response_to | 0.71085859 |
| 92 | MP0008877_abnormal_DNA_methylation | 0.70190616 |
| 93 | MP0005164_abnormal_response_to | 0.68396064 |
| 94 | MP0001663_abnormal_digestive_system | 0.65433387 |
| 95 | MP0000313_abnormal_cell_death | 0.61493594 |
| 96 | MP0001533_abnormal_skeleton_physiology | 0.60171815 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.59505809 |
| 98 | MP0009764_decreased_sensitivity_to | 0.59041447 |
| 99 | MP0002083_premature_death | 0.58119335 |
| 100 | MP0003183_abnormal_peptide_metabolism | 0.57988216 |
| 101 | MP0003795_abnormal_bone_structure | 0.57973225 |
| 102 | MP0005166_decreased_susceptibility_to | 0.57866259 |
| 103 | MP0001851_eye_inflammation | 0.55306695 |
| 104 | MP0001188_hyperpigmentation | 0.54789470 |
| 105 | MP0008873_increased_physiological_sensi | 0.54519916 |
| 106 | MP0004185_abnormal_adipocyte_glucose | 0.53428772 |
| 107 | MP0008995_early_reproductive_senescence | 0.52231057 |
| 108 | MP0003091_abnormal_cell_migration | 0.52142750 |
| 109 | MP0003045_fibrosis | 0.51583525 |
| 110 | MP0004957_abnormal_blastocyst_morpholog | 0.51457051 |
| 111 | MP0005645_abnormal_hypothalamus_physiol | 0.51121499 |
| 112 | MP0003191_abnormal_cellular_cholesterol | 0.51101925 |
| 113 | MP0002063_abnormal_learning/memory/cond | 0.50920269 |
| 114 | MP0005381_digestive/alimentary_phenotyp | 0.50616532 |
| 115 | MP0002693_abnormal_pancreas_physiology | 0.50559731 |
| 116 | MP0003448_altered_tumor_morphology | 0.50499210 |
| 117 | MP0000604_amyloidosis | 0.50435819 |
| 118 | MP0002928_abnormal_bile_duct | 0.50041101 |
| 119 | MP0001486_abnormal_startle_reflex | 0.49213244 |
| 120 | MP0005535_abnormal_body_temperature | 0.47111085 |
| 121 | MP0000249_abnormal_blood_vessel | 0.45712321 |
| 122 | MP0008872_abnormal_physiological_respon | 0.45115280 |
| 123 | MP0003646_muscle_fatigue | 0.44806131 |
| 124 | MP0006082_CNS_inflammation | 0.44786071 |
| 125 | MP0002572_abnormal_emotion/affect_behav | 0.44525029 |
| 126 | MP0009763_increased_sensitivity_to | 0.44269699 |
| 127 | MP0003221_abnormal_cardiomyocyte_apopto | 0.41926047 |
| 128 | MP0009115_abnormal_fat_cell | 0.41177120 |
| 129 | MP0005388_respiratory_system_phenotype | 0.39890356 |
| 130 | MP0002133_abnormal_respiratory_system | 0.39890356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 6.07840942 |
| 2 | Panhypogammaglobulinemia (HP:0003139) | 5.22682865 |
| 3 | Cellulitis (HP:0100658) | 4.84903969 |
| 4 | Chronic otitis media (HP:0000389) | 4.81688913 |
| 5 | Papilloma (HP:0012740) | 4.65072882 |
| 6 | Verrucae (HP:0200043) | 4.65072882 |
| 7 | Recurrent viral infections (HP:0004429) | 4.64710512 |
| 8 | IgM deficiency (HP:0002850) | 4.60861759 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.56078015 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.53892060 |
| 11 | Recurrent bronchitis (HP:0002837) | 4.53021168 |
| 12 | T lymphocytopenia (HP:0005403) | 4.49957092 |
| 13 | Meningitis (HP:0001287) | 4.40396321 |
| 14 | Abnormality of B cell number (HP:0010975) | 4.23963626 |
| 15 | B lymphocytopenia (HP:0010976) | 4.23963626 |
| 16 | Abnormality of T cell number (HP:0011839) | 4.20690964 |
| 17 | Orchitis (HP:0100796) | 4.16954521 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.97911041 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.97801132 |
| 20 | Optic neuritis (HP:0100653) | 3.97801132 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.90055330 |
| 22 | Gastrointestinal infarctions (HP:0005244) | 3.83070462 |
| 23 | Abnormality of T cells (HP:0002843) | 3.75046597 |
| 24 | Thyroiditis (HP:0100646) | 3.72082248 |
| 25 | Gastrointestinal inflammation (HP:0004386) | 3.68233600 |
| 26 | Inflammation of the large intestine (HP:0002037) | 3.66401971 |
| 27 | Recurrent abscess formation (HP:0002722) | 3.62233630 |
| 28 | Chronic sinusitis (HP:0011109) | 3.43501444 |
| 29 | Abnormality of the fingertips (HP:0001211) | 3.40874568 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.35970010 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.35970010 |
| 32 | Spontaneous hematomas (HP:0007420) | 3.34280553 |
| 33 | Lymphopenia (HP:0001888) | 3.33941185 |
| 34 | Colitis (HP:0002583) | 3.33653185 |
| 35 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.23558800 |
| 36 | Recurrent sinusitis (HP:0011108) | 3.20280601 |
| 37 | Thrombocytosis (HP:0001894) | 3.18597483 |
| 38 | Acute lymphatic leukemia (HP:0006721) | 3.14514517 |
| 39 | Severe combined immunodeficiency (HP:0004430) | 3.13523923 |
| 40 | Gingivitis (HP:0000230) | 2.98322581 |
| 41 | Eosinophilia (HP:0001880) | 2.97828372 |
| 42 | Hypochromic microcytic anemia (HP:0004840) | 2.96449668 |
| 43 | Hypochromic anemia (HP:0001931) | 2.96384559 |
| 44 | Combined immunodeficiency (HP:0005387) | 2.95610461 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 2.94930459 |
| 46 | Nasal polyposis (HP:0100582) | 2.94534388 |
| 47 | Pustule (HP:0200039) | 2.94435204 |
| 48 | Papilledema (HP:0001085) | 2.93487675 |
| 49 | Recurrent bacterial skin infections (HP:0005406) | 2.92638206 |
| 50 | Gastrointestinal stroma tumor (HP:0100723) | 2.90271540 |
| 51 | IgG deficiency (HP:0004315) | 2.90072082 |
| 52 | Keratoconjunctivitis sicca (HP:0001097) | 2.89721676 |
| 53 | Urticaria (HP:0001025) | 2.87577639 |
| 54 | Increased IgE level (HP:0003212) | 2.85799443 |
| 55 | Mediastinal lymphadenopathy (HP:0100721) | 2.85639636 |
| 56 | Granulocytopenia (HP:0001913) | 2.84805978 |
| 57 | Abnormality of the nasal mucosa (HP:0000433) | 2.80006659 |
| 58 | Sepsis (HP:0100806) | 2.79473788 |
| 59 | Hypoplasia of the thymus (HP:0000778) | 2.79029704 |
| 60 | Basal cell carcinoma (HP:0002671) | 2.77796493 |
| 61 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.77372435 |
| 62 | Chronic obstructive pulmonary disease (HP:0006510) | 2.76945382 |
| 63 | Obstructive lung disease (HP:0006536) | 2.76945382 |
| 64 | Eczematoid dermatitis (HP:0000976) | 2.74981231 |
| 65 | Autoimmune thrombocytopenia (HP:0001973) | 2.73523202 |
| 66 | Gingival bleeding (HP:0000225) | 2.72705534 |
| 67 | Keratoconjunctivitis (HP:0001096) | 2.69135751 |
| 68 | Increased IgM level (HP:0003496) | 2.57957585 |
| 69 | * Prolonged bleeding time (HP:0003010) | 2.57314841 |
| 70 | Vasculitis (HP:0002633) | 2.56974840 |
| 71 | Recurrent skin infections (HP:0001581) | 2.54874996 |
| 72 | Osteomyelitis (HP:0002754) | 2.53785600 |
| 73 | Bronchitis (HP:0012387) | 2.53684873 |
| 74 | Myositis (HP:0100614) | 2.53330889 |
| 75 | Episodic fever (HP:0001954) | 2.53172380 |
| 76 | Recurrent otitis media (HP:0000403) | 2.50521589 |
| 77 | Autoimmune hemolytic anemia (HP:0001890) | 2.50054738 |
| 78 | Lymphoma (HP:0002665) | 2.45471972 |
| 79 | Abnormality of eosinophils (HP:0001879) | 2.45053947 |
| 80 | Encephalitis (HP:0002383) | 2.44538530 |
| 81 | Chest pain (HP:0100749) | 2.44328535 |
| 82 | Viral hepatitis (HP:0006562) | 2.43356285 |
| 83 | Pulmonary embolism (HP:0002204) | 2.41721343 |
| 84 | Hypergammaglobulinemia (HP:0010702) | 2.34056131 |
| 85 | Arterial thrombosis (HP:0004420) | 2.33419136 |
| 86 | Microcytic anemia (HP:0001935) | 2.28472353 |
| 87 | Limb hypertonia (HP:0002509) | 2.26245268 |
| 88 | Slow saccadic eye movements (HP:0000514) | 2.22639496 |
| 89 | Purpura (HP:0000979) | 2.20845539 |
| 90 | Anorexia (HP:0002039) | 2.19809562 |
| 91 | Skin rash (HP:0000988) | 2.19285839 |
| 92 | Recurrent pneumonia (HP:0006532) | 2.14341253 |
| 93 | Leukocytosis (HP:0001974) | 2.14319634 |
| 94 | Stomatitis (HP:0010280) | 2.13577510 |
| 95 | Emphysema (HP:0002097) | 2.11241350 |
| 96 | Hyperacusis (HP:0010780) | 2.10955951 |
| 97 | Petechiae (HP:0000967) | 2.09638884 |
| 98 | Abnormality of the pleura (HP:0002103) | 2.07459646 |
| 99 | Annular pancreas (HP:0001734) | 2.07418491 |
| 100 | Abnormality of the prostate (HP:0008775) | 2.07161022 |
| 101 | Recurrent lower respiratory tract infections (HP:0002783) | 2.04626012 |
| 102 | Reticulocytopenia (HP:0001896) | 2.03058128 |
| 103 | Abnormality of DNA repair (HP:0003254) | 2.01354285 |
| 104 | * Epistaxis (HP:0000421) | 2.00938109 |
| 105 | Hemoptysis (HP:0002105) | 1.99321626 |
| 106 | Poikiloderma (HP:0001029) | 1.98684344 |
| 107 | Skin ulcer (HP:0200042) | 1.97514993 |
| 108 | Vertebral arch anomaly (HP:0008438) | 1.96345831 |
| 109 | Increased serum ferritin (HP:0003281) | 1.95815589 |
| 110 | Restrictive lung disease (HP:0002091) | 1.94184428 |
| 111 | IgA deficiency (HP:0002720) | 1.93463694 |
| 112 | Acute hepatic failure (HP:0006554) | 1.92300100 |
| 113 | Abnormal number of erythroid precursors (HP:0012131) | 1.91946849 |
| 114 | Neutropenia (HP:0001875) | 1.90453427 |
| 115 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.90145575 |
| 116 | Abnormality of the intervertebral disk (HP:0005108) | 1.89143589 |
| 117 | Seborrheic dermatitis (HP:0001051) | 1.88980032 |
| 118 | Joint swelling (HP:0001386) | 1.88579051 |
| 119 | Abnormal platelet volume (HP:0011876) | 1.87145714 |
| 120 | Glomerulopathy (HP:0100820) | 1.86914454 |
| 121 | Gangrene (HP:0100758) | 1.86891119 |
| 122 | Resting tremor (HP:0002322) | 1.86787836 |
| 123 | Abnormality of iron homeostasis (HP:0011031) | 1.85960266 |
| 124 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.82375886 |
| 125 | Hepatosplenomegaly (HP:0001433) | 1.82146468 |
| 126 | Abnormality of oral frenula (HP:0000190) | 1.82043919 |
| 127 | Impaired platelet aggregation (HP:0003540) | 1.76372335 |
| 128 | Abnormal platelet function (HP:0011869) | 1.76372335 |
| 129 | Hypoproteinemia (HP:0003075) | 1.75214764 |
| 130 | Leukopenia (HP:0001882) | 1.73670158 |
| 131 | Long eyelashes (HP:0000527) | 1.73459264 |
| 132 | Pulmonary infiltrates (HP:0002113) | 1.72555073 |
| 133 | Small epiphyses (HP:0010585) | 1.71866762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.71934391 |
| 2 | MAP3K10 | 3.35923709 |
| 3 | GRK6 | 3.10567817 |
| 4 | EEF2K | 3.02511708 |
| 5 | SIK2 | 3.00935471 |
| 6 | FES | 2.71526961 |
| 7 | BTK | 2.48452785 |
| 8 | TXK | 2.19488743 |
| 9 | SYK | 2.18495886 |
| 10 | RIPK4 | 2.09991361 |
| 11 | STK10 | 2.00169405 |
| 12 | TEC | 1.99895509 |
| 13 | MAP3K13 | 1.98825130 |
| 14 | ITK | 1.93403538 |
| 15 | BLK | 1.91759098 |
| 16 | TNK2 | 1.81514421 |
| 17 | IRAK4 | 1.78757739 |
| 18 | JAK3 | 1.78502584 |
| 19 | ZAP70 | 1.77105551 |
| 20 | HCK | 1.69333358 |
| 21 | TAOK3 | 1.61729702 |
| 22 | TYK2 | 1.61403980 |
| 23 | CLK1 | 1.58053893 |
| 24 | IKBKE | 1.56234961 |
| 25 | EPHA4 | 1.45999264 |
| 26 | LRRK2 | 1.40288669 |
| 27 | PKN2 | 1.36458348 |
| 28 | CSF1R | 1.33792515 |
| 29 | EPHB1 | 1.33672161 |
| 30 | KIT | 1.32772450 |
| 31 | LCK | 1.28146880 |
| 32 | PRKD2 | 1.25962264 |
| 33 | MAP3K11 | 1.23714112 |
| 34 | PRKCH | 1.22634031 |
| 35 | MAP3K3 | 1.20929138 |
| 36 | MARK3 | 1.18253183 |
| 37 | JAK1 | 1.09247791 |
| 38 | NLK | 1.07721045 |
| 39 | LYN | 1.07667981 |
| 40 | CSK | 1.06142271 |
| 41 | FGR | 1.06087842 |
| 42 | CDK4 | 1.05854015 |
| 43 | PASK | 1.03142941 |
| 44 | PIM1 | 1.02741294 |
| 45 | MAP2K3 | 1.01809298 |
| 46 | MAP3K1 | 1.00030579 |
| 47 | MAP3K14 | 0.99698706 |
| 48 | NEK2 | 0.99091472 |
| 49 | MAPK12 | 0.98884165 |
| 50 | MARK2 | 0.96254451 |
| 51 | TAOK1 | 0.95905739 |
| 52 | MAP3K7 | 0.93882810 |
| 53 | ERN1 | 0.89290082 |
| 54 | SMG1 | 0.88375892 |
| 55 | ALK | 0.87627261 |
| 56 | FLT3 | 0.84409025 |
| 57 | BMPR2 | 0.83001408 |
| 58 | MAPK4 | 0.82343884 |
| 59 | IRAK3 | 0.82146449 |
| 60 | STK4 | 0.82008407 |
| 61 | PRKCQ | 0.80986238 |
| 62 | CDC42BPA | 0.77267764 |
| 63 | FGFR3 | 0.76115855 |
| 64 | YES1 | 0.75333768 |
| 65 | SIK1 | 0.73319302 |
| 66 | BRD4 | 0.73143694 |
| 67 | KDR | 0.72394938 |
| 68 | KSR2 | 0.72115398 |
| 69 | CDK12 | 0.71167452 |
| 70 | SIK3 | 0.70817129 |
| 71 | PDK1 | 0.69467936 |
| 72 | CAMKK2 | 0.67907314 |
| 73 | SGK3 | 0.66308934 |
| 74 | PTK6 | 0.64535682 |
| 75 | TRIB3 | 0.64526813 |
| 76 | DAPK1 | 0.63439334 |
| 77 | HIPK2 | 0.62653500 |
| 78 | IKBKB | 0.61755853 |
| 79 | CDC7 | 0.61742940 |
| 80 | IRAK2 | 0.60982412 |
| 81 | FGFR4 | 0.60418475 |
| 82 | IRAK1 | 0.60214560 |
| 83 | MAPK7 | 0.58532995 |
| 84 | TAOK2 | 0.58332725 |
| 85 | TNIK | 0.58116383 |
| 86 | DYRK1B | 0.57865122 |
| 87 | RPS6KB2 | 0.57274146 |
| 88 | ATR | 0.56057678 |
| 89 | RPS6KA6 | 0.55386912 |
| 90 | CDK19 | 0.54704385 |
| 91 | TBK1 | 0.53708058 |
| 92 | MAPK11 | 0.53645017 |
| 93 | CAMKK1 | 0.52407905 |
| 94 | STK24 | 0.52032558 |
| 95 | RPS6KL1 | 0.50075035 |
| 96 | RPS6KC1 | 0.50075035 |
| 97 | JAK2 | 0.49693332 |
| 98 | MAP2K2 | 0.49610339 |
| 99 | TGFBR2 | 0.49289309 |
| 100 | NTRK2 | 0.47139814 |
| 101 | CAMK1 | 0.47082690 |
| 102 | STK11 | 0.46715406 |
| 103 | CDK6 | 0.46543063 |
| 104 | PIK3CG | 0.45753112 |
| 105 | RAF1 | 0.45741954 |
| 106 | SGK2 | 0.45513470 |
| 107 | RET | 0.44403032 |
| 108 | MATK | 0.43043449 |
| 109 | STK38 | 0.42515964 |
| 110 | FYN | 0.42382753 |
| 111 | PTK2B | 0.41862366 |
| 112 | BMX | 0.38423439 |
| 113 | RPS6KA2 | 0.38044608 |
| 114 | PRPF4B | 0.37304029 |
| 115 | MAP3K6 | 0.37065358 |
| 116 | EIF2AK3 | 0.34367140 |
| 117 | TRPM7 | 0.31457058 |
| 118 | TTN | 0.30188241 |
| 119 | MELK | 0.28791494 |
| 120 | ABL1 | 0.27982887 |
| 121 | CAMK4 | 0.27978914 |
| 122 | MAPKAPK2 | 0.27342301 |
| 123 | MAP3K8 | 0.27020500 |
| 124 | PRKD1 | 0.25508452 |
| 125 | BRSK1 | 0.25308416 |
| 126 | CHEK1 | 0.24794737 |
| 127 | TESK2 | 0.24393396 |
| 128 | PDPK1 | 0.22602146 |
| 129 | CDK2 | 0.22224635 |
| 130 | MAP2K6 | 0.21903171 |
| 131 | MAPK3 | 0.21725792 |
| 132 | CDK9 | 0.21647133 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.35983793 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.42941888 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.67212717 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.65205335 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.56299833 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.49325682 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.38078862 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.25552361 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.14948361 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.07441468 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.95560443 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.90908567 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.86828586 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79178803 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.75979728 |
| 16 | Mismatch repair_Homo sapiens_hsa03430 | 1.74421730 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.73354320 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.72047161 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.71929602 |
| 20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.68033575 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.65915496 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.58904841 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.58800909 |
| 24 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.56762546 |
| 25 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.53218717 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.51743024 |
| 27 | Morphine addiction_Homo sapiens_hsa05032 | 1.45486034 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40397305 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.37027589 |
| 30 | Ribosome_Homo sapiens_hsa03010 | 1.32590010 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.30832706 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.24797612 |
| 33 | * Platelet activation_Homo sapiens_hsa04611 | 1.23863223 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.19583038 |
| 35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.17933532 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16346646 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.14979241 |
| 38 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.10596009 |
| 39 | Homologous recombination_Homo sapiens_hsa03440 | 1.10579150 |
| 40 | Spliceosome_Homo sapiens_hsa03040 | 1.09980243 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.04647038 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.04539374 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.03675018 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02303696 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 0.98107600 |
| 46 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.97469621 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.94609505 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 0.93510822 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.93455490 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 0.93403478 |
| 51 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.93177711 |
| 52 | Long-term potentiation_Homo sapiens_hsa04720 | 0.91547336 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.91036417 |
| 54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.90231340 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90213774 |
| 56 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89895333 |
| 57 | Cocaine addiction_Homo sapiens_hsa05030 | 0.89322026 |
| 58 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.88370233 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.86640048 |
| 60 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.86483627 |
| 61 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.85594222 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84301276 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83418782 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80929309 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.80265102 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76910731 |
| 67 | Influenza A_Homo sapiens_hsa05164 | 0.76783067 |
| 68 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74441076 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73539664 |
| 70 | Circadian entrainment_Homo sapiens_hsa04713 | 0.72936684 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72792195 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70890006 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70545941 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.69812692 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.69736318 |
| 76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69082571 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.68897880 |
| 78 | Tuberculosis_Homo sapiens_hsa05152 | 0.68757506 |
| 79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.68090071 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.66888598 |
| 81 | Apoptosis_Homo sapiens_hsa04210 | 0.65933650 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65804976 |
| 83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65767068 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65218165 |
| 85 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.64033474 |
| 86 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.63386116 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.63002390 |
| 88 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.62623813 |
| 89 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.62249103 |
| 90 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.62139387 |
| 91 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61881247 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60809097 |
| 93 | Renin secretion_Homo sapiens_hsa04924 | 0.59713974 |
| 94 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.59370309 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58979399 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58609607 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58545755 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58102970 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57558344 |
| 100 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.55712707 |
| 101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54776126 |
| 102 | Alcoholism_Homo sapiens_hsa05034 | 0.54537606 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54470697 |
| 104 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54365421 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54351344 |
| 106 | Salmonella infection_Homo sapiens_hsa05132 | 0.53782792 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52980996 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52346525 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.52321658 |
| 110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52242444 |
| 111 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52235110 |
| 112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52199881 |
| 113 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.49478107 |
| 114 | Salivary secretion_Homo sapiens_hsa04970 | 0.49268352 |
| 115 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.48050173 |
| 116 | Pertussis_Homo sapiens_hsa05133 | 0.47901367 |
| 117 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.47882239 |
| 118 | RNA degradation_Homo sapiens_hsa03018 | 0.45759595 |
| 119 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45739845 |
| 120 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45234509 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44638892 |
| 122 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44310623 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44209137 |
| 124 | Prostate cancer_Homo sapiens_hsa05215 | 0.43664665 |
| 125 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43224126 |
| 126 | Cell cycle_Homo sapiens_hsa04110 | 0.42850548 |
| 127 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42530135 |
| 128 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.41573793 |
| 129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40931066 |
| 130 | Thyroid cancer_Homo sapiens_hsa05216 | 0.40884081 |
| 131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40741959 |
| 132 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40530586 |
| 133 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40460818 |
| 134 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40254454 |
| 135 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38921205 |
| 136 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38811907 |
| 137 | Amoebiasis_Homo sapiens_hsa05146 | 0.34003448 |
| 138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32947633 |

